Search

everythinglearnresearchcommunity

for

Search:↓

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Skin reactions from cancer treatments might predict how well the treatments work.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

Some common medications can harm male fertility, but many effects can be reversed.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Hair loss can signal serious health issues, not just cosmetic concerns.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

Hair turning darker can be a sign of skin cancer.

More melanoblasts in hair follicles mean better survival and proper hair pigmentation.